Résumé
Environ un tiers des bactériémies concerne des patients âgés de plus de 85 ans. Elles sont associées à des taux de mortalité et de morbidité accrus dans cette population. La présentation clinique est atypique avec une diminution des signes spécifiques d’infection et la présence de signes aspécifiques comme l’altération de l’état général ou les chutes. Les portes d’entrée les plus fréquentes sont urinaires, pulmonaires et digestives. Les bacilles Gram négatif, en particulier Escherichia coli, sont les bactéries les plus fréquemment isolées et de manière plus élevée que dans la population jeune. La gravité du sepsis est déterminante dans la prise en charge ainsi que l’initiation rapide d’un traitement antibiotique probabiliste et le traitement de la porte d’entrée infectieuse. Le taux de mortalité se situe entre 10 et 30 % selon les études. Les facteurs de risque de mortalité sont principalement les comorbidités, les statuts fonctionnel et nutritionnel, le délai de mise en route d’une antibiothérapie adaptée et le caractère nosocomial de l’infection. La porte d’entrée urinaire est un facteur protecteur.
Abstract
Around one third of the bacteremia episodes concerned elderly population (> 85 years old) with a poorer mortality and morbidity rate compared to younger patients. Atypical clinical presentation (absence of fever, presence of falls or delirium) makes diagnosis difficult. The most prevalent portals of entry are the urinary tract infection, pneumonia and digestive infections. Gram-negative bacilli (especially Escherichia coli) are more often identified than in the younger population. The bacteremia management is based on the evaluation of the severity of the sepsis, the timely initiation of an empirical antibiotic therapy and the treatment of the source of infection. Mortality rate is between 10 and 30%in the literature. Comorbidities, functional and nutritional status, inappropriate antibiotic therapy and nosocomially acquired bacteremia are the most prevalent risk factor for death, an urinal portal of entry was a protective factor.
Références
Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. New Engl J 348:1546–54
Martin GS, Mannino DM, Moss M (2006) The effect of age on the development and outcome of adult sepsis. Crit Care Med 34:15–21
Russo TA, Johnson JR (2003) Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect 5:449–56
Gavazzi G, Krause KH (2002) Ageing and infection. Lancet infect Dis 2:659–66
Girard TD, Ely EW (2007) Bacteremia and sepsis in older adults. Clinics Geriatr Med 23:633–47
Dellinger RP, Levy MM, Rhodes A, et al (2013) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intens Care Med 39:165–228
Brun-Buisson C, Meshaka P, Pinton P, Vallet B (2004) EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intens Care Med 30:580–8
Angus DC, Linde-Zwirble WT, Lidicker J, et al (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303–10
Baine WB, Yu W, Summe JP (2001) The epidemiology of hospitalization of elderly Americans for septicemia or bacteremia in 1991–1998. Application of Medicare claims data. Ann Epidemiol 11:118–26
Uslan DZ, Crane SJ, Steckelberg JM, et al (2007) Age- and sexassociated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota. Arch Intern Med 167:834–9
Crane SJ, Uslan DZ, Baddour LM (2007) Bloodstream infections in a geriatric cohort: a population-based study. Am J Med 120:1078–83
Lee CC, Chang CM, Hong MY, et al (2013) Different impact of the appropriateness of empirical antibiotics for bacteremia among younger adults and the elderly in the ED. Am J Emerg Med 31:282–90
Lee CC, Chen SY, Chang IJ, et al (2007) Comparison of clinical manifestations and outcome of community-acquired bloodstream infections among the oldest old, elderly, and adult patients. Medicine 86:138–44
Sogaard M, Schonheyder HC, Riis A, et al (2008) Short-term mortality in relation to age and comorbidity in older adults with community-acquired bacteremia: a population-based cohort study. J Am Geriatr Soc 56:1593–600
Green JE, Ariathianto Y, Wong SM, et al (2014) Clinical and inflammatory response to bloodstream infections in octogenarians. BMC Geriatr 14:55
Retamar P, Lopez-Prieto MD, Rodriguez-Lopez F, et al (2014) Predictors of early mortality in very elderly patients with bacteremia: a prospective multicenter cohort. Int J Infect Dis 26C:83–7
Gavazzi G, Mallaret MR, Couturier P, et al (2002) Bloodstream infection: differences between young-old, old, and old-old patients. J Am Geriatr Soc 50:1667–73
Esposito AL, Gleckman RA, Cram S, et al (1980) Communityacquired bacteremia in the elderly: analysis of one hundred consecutive episodes. J Am Geriatr Soc 28:315–9
Lark RL, Saint S, Chenoweth C, et al (2001) Four-year prospective evaluation of community-acquired bacteremia: epidemiology, microbiology, and patient outcome. Diagn Microbiol Infect Dis 41:15–22
Laupland KB, Gregson DB, Church DL, et al (2008) Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region. Clin Microbiol Infect 14:1041–7
Burlaud A, Mathieu D, Falissard B, Trivalle C (2010) Mortality and bloodstream infections in geriatrics units. Arch Gerontol Geriatr 51:e106–9
McClelland RS, Fowler VG, Jr., Sanders LL, et al (1999) Staphylococcus aureus bacteremia among elderly vs younger adult patients: comparison of clinical features and mortality. Arch Intern Med 159:1244–7
Reunes S, Rombaut V, Vogelaers D, et al (2011) Risk factors and mortality for nosocomial bloodstream infections in elderly patients. Eur J Intern Med 22:e39–44
Roubaud Baudron C, Panhard X, Clermont O, et al (2014) Escherichia coli bacteraemia in adults: age-related differences in clinical and bacteriological characteristics, and outcome. Epidemiol Infect 20:1–12
Ku NS, Kim YC, Kim MH, et al (2014) Risk factors for 28-day mortality in elderly patients with extended-spectrum betalactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae bacteremia. Arch Gerontol Geriatr 58:105–9
Rodriguez-Bano J, Pascual A (2008) Clinical significance of extended-spectrum beta-lactamases. Expert Rev Anti Infect Ther 6:671–83
Marchaim D, Gottesman T, Schwartz O, et al (2010) National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother 54:5099–104
Kizilbash QF, Petersen NJ, Chen GJ, et al (2013) Bacteremia and mortality with urinary catheter-associated bacteriuria. Infect Control Hospit Epidemiol 34:1153–9
Valenti WM, Trudell RG, Bentley DW (1978) Factors predisposing to oropharyngeal colonization with Gram-negative bacilli in the aged. New Engl J Med 298:1108–11.
Gleckman R, Hibert D (1982) Afebrile bacteremia. A phenomenon in geriatric patients. JAMA 248:1478–81
Wester AL, Dunlop O, Melby KK, et al 2013 Age-related differences in symptoms, diagnosis and prognosis of bacteremia. BMC Infect Dis 13:346
Jarrett PG, Rockwood K, Carver D, et al (1995) Illness presentation in elderly patients. Arch Intern Med 155:1060–4
Boddaert J, Gavazzi G. Biomarqueurs chez le patient âgé aux urgences in Les biomarqueurs en médecine d’urgence. Références en médecine d’urgence. Collection de la SFMU. 2012, pp 337–49
Van Nieuwkoop C, Bonten TN, van Wout JW (2010) Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study. Crit Care 14:R206
Van Duin D (2012) Diagnostic challenges and opportunities in older adults with infectious diseases. Clin Infect Dis 54:973–78
Liu A, Bui T, Van Nguyen H, et al (2010) Serum C-reactive protein as a biomarker for early detection of bacterial infection in the older patient. Age Ageing 39:559–65
Bates DW, Cook EF, Goldman L, Lee TH (1990) Predicting bacteremia in hospitalized patients. A prospectively validated model. Ann Intern Med 113:495–500
Coburn B, Morris AM, Tomlinson G, Detsky AS (2012) Does this adult patient with suspected bacteremia require blood cultures? JAMA 308:502–11
Taniguchi T, Tsuha S, Takayama Y, Shiiki S (2013) Shaking chills and high body temperature predict bacteremia especially among elderly patients. Springerplus 2:624
Brun-Buisson C, Doyon F, Carlet J (1996) Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia-Sepsis Study Group. Am J Resp Critic Care Med 154:617–24
Laupland KB, Gregson DB, Zygun DA, et al (2004) Severe bloodstream infections: a population-based assessment. Critic Care Med 32:992–7
Laupland KB, Gregson DB, Flemons WW, et al (2007) Burden of community-onset bloodstream infection: a population-based assessment. Epidemiol Infect 135:1037–42
Leibovici L, Samra Z, Konigsberger H, et al (1995) Long-term survival following bacteremia or fungemia. JAMA 274:807–12
Bates DW, Pruess KE, Lee TH (1995) How bad are bacteremia and sepsis? Outcomes in a cohort with suspected bacteremia. Arch Intern Med 155:593–8
Lillie PJ, Allen J, Hall C, et al (2013) Long-term mortality following bloodstream infection. Clinic Microbiol Infect 19:955–60
Gavazzi G, Escobar P, Olive F, et al (2005) Nosocomial bacteremia in very old patients: predictors of mortality. Aging Clinic Exp Res 2005 17:337–42
Jaureguy F, Carbonnelle E, Bonacorsi S, et al (2007) Host and bacterial determinants of initial severity and outcome of Escherichia coli sepsis. Clin Microbiol Infect 13:854–62
Tumbarello M, Sali M, Trecarichi EM, et al (2008) Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. Antimicrob Agents Chemother 52:3244–52
Melzer M, Petersen I (2007) Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli. J Infect 55:254–9
Bone RC, Balk RA, Cerra FB, et al (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644–55
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Roubaud-Baudron, C., Gavazzi, G. Épidémiologie des bactériémies chez le sujet âgé. cah. année gerontol. 6, 102–106 (2014). https://doi.org/10.1007/s12612-014-0404-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12612-014-0404-8